Publications
Our publications
Citation
EDHF-mediated rapid restoration of hypotensive response to acetylcholine after chronic, but not acute, nitric oxide synthase inhibition in rats.
Eur J Pharmacol . 2006 Jul 05 ; 546(1-3) 120 | DOI : 10.1016/j.ejphar.2006.06.072
- KM. Desai
- et al
Products : Charybdotoxin - 0.1 mg — AS-28244
Citation
Chronic clofibrate administration prevents saline-induced endothelial dysfunction and oxidative stress in young Sprague-Dawley rats.
Clin Invest Med. . 2008 Apr 01 ; 31(2) E62 | DOI : 10.25011/cim.v31i2.3365
- S. Sankaralingam
- et al
Products : Charybdotoxin - 0.1 mg — AS-28244
Citation
RGD peptides induce relaxation of pulmonary arteries and airways via β3-integrins.
FASEB J . 2014 Feb 05 ; 28(5) 2281 | DOI : 10.1096/fj.13-246348.
- J. Welschoff
- et al
Products : Charybdotoxin - 0.1 mg — AS-28244
Citation
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.
J Immunol . 2001 Sep 01 ; 255(1-2) 27 | DOI : 10.1016/s0022-1759(01)00416-1
- HT. Maecker
- et al
Products : CEF20, Cytomegalovirus, CMV pp65 (495-503) - 1 mg — AS-28328
Citation
Transduction with the antioxidant enzyme catalase protects human T Cells against oxidative stress.
J Immunol . 2008 Dec 15 ; 181(12) 8382 | DOI : 10.4049/jimmunol.181.12.8382
- T. Ando
- et al
Products : CEF20, Cytomegalovirus, CMV pp65 (495-503) - 1 mg — AS-28328
Citation
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
J Immunol . 2013 Jul 12 ; 191(4) 1567 | DOI : 10.4049/jimmunol.1300080.
- JP. Goodridge
- et al
Products : CEF20, Cytomegalovirus, CMV pp65 (495-503) - 1 mg — AS-28328
Citation
Sperm-derived SPANX-B is a clinically relevant tumor antigen that is expressed in human tumors and readily recognized by human CD4+ and CD8+ T cells.
Clin. Cancer Res. . 2009 Mar 10 ; 15(6) 1954 | DOI : 10.1158/1078-0432.CCR-08-1290
- G. Almanzar
- et al
Products : CEF1, Influenza Matrix Protein M1 (58-66) - 1 mg — AS-28310
Citation
Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials.
J Immunol Methods . 2006 Aug 15 ; 315(1-2) 121 | DOI : 10.1016/j.jim.2006.07.015
- Z. Moodie
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials.
J Immunol Methods . 2007 Feb 28 ; 322(1-2) 57 | DOI : 10.1016/j.jim.2007.02.003
- M. Bull
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
J Exp Med . 2008 Nov 10 ; 205(12) 2763 | DOI : 10.1084/jem.20081398.
- RB. Jones
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025